Advertisement

Topics

Oxford Outcomes Company Profile

22:31 EST 13th December 2018 | BioPortfolio

Oxford Outcomes is an international consultancy which specialises in patient-reported outcomes, health economics, epidemiology and health programme evaluation. The company has offices in Oxford and Vancouver, as well as a new office opened in Washington D.C. in June 2006. The consultancy team isled by Diane Wild, Andrew Briggs, Adrian Levy, Maggie Tabberer, Kathy Beusterien and Mark Sculpher, supported by staff of considerable expertise

Location

7272 Wisconsin Ave, Suite 300
Bethesda
Maryland
20814
United States of America

Contact

Phone: (1) 301 941 1916
Email: enquiries@oxfordoutcomes.com


News Articles [354 Associated News Articles listed on BioPortfolio]

Nitric Oxide conference gets under way in Oxford

Delegates from round the world have descended on Oxford for the 10th international conference of the Nitric Oxide Society, which has got under way. This year, the NIHR oxford Biomedical Research Centr...

ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) Injection was ...

PARIS and TARRYTOWN, N.Y., Nov. 11, 2018 /PRNewswire/ -- New analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Read more...

Amgen Invests $66 Million in Oxford Nanopore Technologies

THOUSAND OAKS, Calif. and OXFORD, England, Oct. 18, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies Ltd. today announced Amgen’s equity investment of £5...

Oxford Firm Launches to Develop Quantum-Era Sensor Technology

Oxford HighQ, a spinout from Oxford University, aims to revolutionise chemical and nanoparticle sensor technology with ‘quantum’ sensors up to 10,000 times more sensitive than current coun...

Oxford woman sheds nearly six stone after diabetes diagnosis – Oxford Mail

Oxford MailOxford woman sheds nearly six stone after diabetes diagnosisOxford MailA DIABETES diagnosis was a wake-up call for one Oxford woman who has now shed nearly six stone. 0 comment. Retired nur...

Parental controls do not stop teens from seeing pornography, new research finds

(University of Oxford) New research from the Oxford Internet Institute, University of Oxford has found that Internet filtering tools are ineffective and in most cases, were an insignificant factor in ...

Oxford Immunotec (OXFD) - Not your usual diagnostics company

Edison Investment Research - Pharmaceutical & healthcare - Oxford Immunotec: Oxford Immunotec is in transition. Having passed the stage before which most diagnostic companies stall – their first...

Oxford Impact 2018 workshop

Last month, the NIHR Oxford BRC and the UK Cochrane Collaboration organised the Oxford Impact 2018 workshop, which brought together people from a wide range of fields to “think differently about res...

Drugs and Medications [0 Results]

None

PubMed Articles [601 Associated PubMed Articles listed on BioPortfolio]

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial.

The ODYSSEY OUTCOMES trial compared alirocumab with placebo, added to high-intensity or maximum tolerated statin treatment, after acute coronary syndrome (ACS) in 18,924 patients. Alirocumab reduced t...

Cross-cultural adaptation and validation of the Romanian Oxford Shoulder Score.

The use of validated patient reported outcome scores is critical to the reporting and monitoring of the effectiveness of clinical treatment. The aim of this study was to translate and culturally valid...

BulkVis: a graphical viewer for Oxford nanopore bulk FAST5 files.

The Oxford Nanopore Technologies (ONT) MinION is used for sequencing a wide variety of sample types with diverse methods of sample extraction. Nanopore sequencers output FAST5 files containing signal ...

Cross-cultural adaptation and validation of the Portuguese version of the Oxford Shoulder Score (OSS).

To translate and culturally adapt the Oxford Shoulder Score (OSS) to the European Portuguese language, and to test its reliability (internal consistency, reproducibility and measurement error) and val...

The perils of PROMs: question 5 of the Oxford Hip Score is ambiguous to 10% of English-speaking patients: a survey of 135 patients.

The Oxford Hip Score (OHS) is a commonly used patient-reported outcome measure (PROM), comprising 12 questions. We present the incidental finding that one of the 12 questions is ambiguous.

Clinical Trials [122 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [203 Associated Companies listed on BioPortfolio]

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutic...

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

More Information about "Oxford Outcomes" on BioPortfolio

We have published hundreds of Oxford Outcomes news stories on BioPortfolio along with dozens of Oxford Outcomes Clinical Trials and PubMed Articles about Oxford Outcomes for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Outcomes Companies in our database. You can also find out about relevant Oxford Outcomes Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record